Browsing by Author "Navarro Mendivil, Alejandro"
Now showing items 1-10 of 10
-
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
Byers, Lauren Averett; Navarro Mendivil, Alejandro; Schaefer, Eric; Johnson, Melissa L.; Özgüroglu, Mustafa; Han, Ji-Youn (Elsevier, 2021-11) -
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
Shaw, Alice Tsang; Johnson, Melissa L.; Navarro Mendivil, Alejandro; Gainor, Justin F.; Thurm, Holger; Felip Font, Enriqueta; Bauer, Todd (Springer, 2020-02) -
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
Cedres Perez, Susana; Assaf, Juan David; Iranzo Gómez, Patricia; Callejo Perez, Ana; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Marmolejo Castañeda, David; Rezqallah Aron, Maria Alejandra; Amat, Ramon; Pedrola Gómez, Anna; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan; Dienstmann, Rodrigo (Nature Research, 2021-11-01) -
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Iranzo Gómez, Patricia; Pardo Aranda, Nuria; Callejo Perez, Ana; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Soleda, Mireia; Jiménez Flores, José Antonio; Hernandez Losa, Javier; Vivancos Prellezo, Ana; Felip Font, Enriqueta; Amat, Ramon; Carbonell, Caterina; Frigola Rissech, Joan (BMJ, 2022-04) -
Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
Callejo Perez, Ana; Iranzo Gómez, Patricia; Diaz-Mejia, Nely; Marmolejo Castañeda, David; Assaf, Juan David; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Pardo Aranda, Nuria; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (MDPI, 2021-07) -
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Navarro Mendivil, Alejandro; Callejo Perez, Ana; Iranzo Gómez, Patricia; Cedres Perez, Susana; Martínez Marti, Alexandre; Pardo Aranda, Nuria; Jiménez Flores, José Antonio; Sansano Valero, Irene; Mancuso, Francesco Mattia; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Felip Font, Enriqueta; Amat, Ramon; Saoudi Gonzalez, Nadia; Carbonell, Caterina; Frigola Rissech, Joan (Wiley, 2021-04) -
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
Owonikoko, Taofeek; Park, Keunchil; Govindan, Ramaswamy; Ready, Neal; Reck, M.; Peters, S.; Navarro Mendivil, Alejandro (Lippincott Williams & Wilkins, 2021-04-20) -
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
Iranzo Gómez, Patricia; Callejo Perez, Ana; Assaf Pastrana, Juan David; Molina, Gaspar; Lopez, Daniel Esteban; García Illescas, David; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Cedres Perez, Susana; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (Frontiers Media, 2022-05-30) -
Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer
Santoro, Armando; Su, Wu-Chou; Navarro Mendivil, Alejandro; Simonelli, Matteo; Yang, James C. H.; Ardizzoni, Andrea; Felip Font, Enriqueta (Elsevier, 2022-04) -
Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis
Trigo, José Manuel; Sanchez Gastaldo, Amparo; Navarro Mendivil, Alejandro; Perez, Coral; Crama, Leonardo; Arriola, Edurne; Ponce Aix, Santiago (Elsevier, 2022-01-01)